Cargando…
Effectiveness of mesalazine to treat irritable bowel syndrome: A meta-analysis
AIM: Accumulating evidence has explored the effect of mesalazine on irritable bowel syndrome (IBS). However, these studies remain inconsistent. Thus, a meta-analysis was conducted to estimate the role of mesalazine on IBS. METHODS: PubMed, Medline, Embase, Web of Science, and the Cochrane Library Da...
Autores principales: | Zhang, Fen-Ming, Li, Sha, Ding, Liang, Xiang, Sai-Heng, Zhu, Hua-Tuo, Yu, Jing-Hua, Xu, Guo-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6641673/ https://www.ncbi.nlm.nih.gov/pubmed/31305414 http://dx.doi.org/10.1097/MD.0000000000016297 |
Ejemplares similares
-
Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome
por: Dorofeyev, Andrey E, et al.
Publicado: (2011) -
Randomised clinical trial and meta‐analysis: mesalazine treatment in irritable bowel syndrome—effects on gastrointestinal symptoms and rectal biomarkers of immune activity
por: Castro Tejera, Valeria, et al.
Publicado: (2022) -
Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial
por: Leighton, Matthew P, et al.
Publicado: (2013) -
Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015) -
Colonic Gene Expression and Fecal Microbiota in Diarrhea-predominant Irritable Bowel Syndrome: Increased Toll-like Receptor 4 but Minimal Inflammation and no Response to Mesalazine
por: Jalanka, Jonna, et al.
Publicado: (2021)